fbpx
September 9, 2021

Mobile Stroke Units Linked to Reduced Stroke Disability Mobile Stroke Units Linked to Reduced Stroke Disability

Treatment in a mobile stroke unit (MSU) is associated with better functional outcomes, compared with treatment by emergency medical services (EMS), among patients with acute ischemic […]
September 9, 2021

New Data on Antithrombotics After ICH: Is There a Net Benefit? New Data on Antithrombotics After ICH: Is There a Net Benefit?

New data from three randomized clinical trials on the risks and benefits of antithrombotic drugs for patients who have an indication for such treatment but have […]
September 8, 2021

Positive Topline Results for Novel Parkinson’s Treatment Positive Topline Results for Novel Parkinson’s Treatment

Topline results from a study that tested two lead structurally targeted allosteric regulator (STAR) compounds ― GT-02287 and GT-02329 ― are promising for the treatment of […]
September 7, 2021

New Tool More Accurately Predicts Aneurysm Rupture Risk New Tool More Accurately Predicts Aneurysm Rupture Risk

A simple prediction model may accurately predict aneurysm rupture within 1 year after growth is detected on imaging, new research shows.    The “triple-S” prediction model […]
September 7, 2021

MR ASAP: No Benefit of Prehospital Nitroglycerin in Stroke MR ASAP: No Benefit of Prehospital Nitroglycerin in Stroke

Giving transdermal nitroglycerin to stroke patients in the ambulance within 3 hours of symptom onset was not shown to be of any benefit in the MR […]
September 3, 2021

Early BP Variability After ICH Predicts Disability Early BP Variability After ICH Predicts Disability

Greater short-term variability in systolic blood pressure after intracerebral hemorrhage (ICH) is associated with an increased risk for long-term disability, new research suggests. A pooled analysis […]
September 3, 2021

Cerebral Thrombosis After COVID Vax Deadlier Than Sporadic Form Cerebral Thrombosis After COVID Vax Deadlier Than Sporadic Form

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The cerebral venous thrombosis (CVT) that occurs as part of the rare […]
September 3, 2021

FDA Approves Intranasal DHE (Trudhesa) for Acute Migraine FDA Approves Intranasal DHE (Trudhesa) for Acute Migraine

The US Food and Drug Administration (FDA) has approved an intranasal formulation of dihydroergotamine mesylate (DHE) for the acute treatment of migraine with or without aura […]
September 2, 2021

MS Plus Depression May Up Risk for Death, Vascular Disease MS Plus Depression May Up Risk for Death, Vascular Disease

People with multiple sclerosis (MS) and depression have an increased risk of death, compared with those with one or neither condition, as well as an increased […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0